Home > Result Summaries: Compounds > SRT2104 > Result Summary for 114009

Result Summary for 114009

Result Summary

Protocol ID:	114009
Clinical Study ID:	SIR114009
Official Title:	A Phase I study to evaluate single and multiple (seven) oral doses of SRT2104 on the endotoxin induced inflammatory response in healthy male subjects
Phase:	phase 1
Study Indications or Diseases:	Sepsis
Generic Name:	SRT2104
Trade/Product Name:	SRT2104
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	van der meer, AJ, Scicluno, B, Lin, J, Jacobson, EW, Vlasuk, GP, van der Poll. The first demonstration of clinical activity by a small molcule SIRT1 activator: SRT 2104 reduces cytokine release and coagulation activation in a human enotoxin model. [Inflammation Research]. 2011;60(Supplement 1):S1-321.